The FDA has advised doctors to limit prescriptions of the pain medications Celebrex and Bextra because some data show they may increase the risk of heart attack and stroke. Diane and her guests talk about drug safety, the FDA’s approval process and the agency’s relationship with pharmaceutical companies.

Guests

  • Gardiner Harris science reporter for "The New York Times"
  • Dr. Paul Antony chief medical officer for the Pharmaceutical Research and Manufacturers of America
  • Dr. Janet Woodcock deputy commissioner and chief medical officer of the FDA

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

“The Anatomy Of Love,” 25 Years Later

Thursday, Feb 11 2016In the early nineties, anthropologist Helen Fisher wrote “The Anatomy of Love: A Natural History of Mating, Marriage, and Why We Stray.” Now she’s back with the latest research on how love affects the brain and how the Internet has changed dating.

Erika Christakis: “The Importance Of Being Little”

Wednesday, Feb 10 2016Walk into a pre-school classroom in America today and Erika Christakis says it’s likely you’ll see some familiar décor: alphabet charts, bar graphs, calendars, and schedules. It’s all part, says the expert in early child education, of a nationwide drive to make sure kids are ready for school at a younger and younger age.

Analysis Of The New Hampshire Primary

Wednesday, Feb 10 2016New Hampshire holds the nation's first primary election. The winners, the losers and what the results could mean for the presidential candidates vying for the Democratic and Republican nominations.